Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lung Neoplasms × Hematologic Tests × Clear all

Phase

Phase NA 4 Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Cisplatin 50 Carboplatin 49 Radiotherapy 33 Paclitaxel 28 Docetaxel 26 Pemetrexed 24 Gemcitabine 24 Etoposide 21 pembrolizumab 18 Vinorelbine 16 Drug Therapy 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 9 Erlotinib Hydrochloride 9 Specimen Handling 8 Nivolumab 8 durvalumab 7 Gefitinib 6 Cyclophosphamide 6 Bevacizumab 6 Topotecan 5 Surgical Procedures, Operative 5 Standard of Care 5 Platinum 5 Dexamethasone 5 atezolizumab 4 Vinblastine 4 Immunoglobulin G 4 Ifosfamide 4 Doxorubicin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01687647 2014-04-09

AMORCE-CBP

University Hospital, Caen

Phase 3 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡